5 companies in Illumina Ventures's investment portfolio.
Back to Illumina Ventures profile“Invests in genomics and digital health startups that leverage genomic data to improve human health outcomes.”
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Population genomics company providing DNA testing and genetic insights for consumers and healthcare providers.
Sophia Genetics SA is a Swiss-founded data-driven medicine software company with headquarters in Rolle, Switzerland and Boston, Massachusetts, as well as offices in France.
Genomic diagnostics company that develops molecular tests to help physicians make treatment decisions for patients with thyroid, lung, and breast diseases.
Illumina Ventures has built a portfolio of 5 companies across 2 sectors, including Biotech, DevTools.
The portfolio reflects investments across the IPO, Series B stages, showing Illumina Ventures's approach to supporting companies at multiple points in their growth journey.
Illumina Ventures has invested in 5+ companies across 2 different sectors.
Illumina Ventures's portfolio spans Biotech, DevTools. This diversification reflects the firm's broad investment thesis and sector expertise.
Illumina Ventures invests across the IPO, Series B stages. Their portfolio includes companies at various points in their growth journey.